Earnings call transcript: Coherus Oncology posts Q2 2026 EPS beat, shares fall — See source for full details.
$CHRS
Price history, market instrument context, member research, and related headlines in one place.
CHRS key statistics
NasdaqGMUSD
52-week range
$0.9745%$2.62
Latest session $1.01–$1.09Coherus Oncology, Inc. (CHRS) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $1.05, down $0.02 (1.87%) from the previous close of $1.07. It has traded between $1.01 and $1.09 in the latest session. Over the past year it has ranged from $0.974 to $2.62, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 1.7M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $CHRS research…